Wellington Management Group’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-70,778
Closed -$6.02M 2067
2020
Q3
$6.02M Buy
+70,778
New +$3.58M ﹤0.01% 1228
2020
Q1
Sell
-63,707
Closed -$1.35M 2128
2019
Q4
$1.35M Buy
+63,707
New +$1.12M ﹤0.01% 1639
2019
Q3
Sell
-28,415
Closed -$394K 2162
2019
Q2
$394K Hold
28,415
﹤0.01% 1941
2019
Q1
$546K Buy
+28,415
New +$458K ﹤0.01% 1887
2018
Q1
Sell
-68,177
Closed -$1.1M 2382
2017
Q4
$1.1M Sell
68,177
-83,170
-55% -$982K ﹤0.01% 1876
2017
Q3
$2.12M Buy
+151,347
New +$1.51M ﹤0.01% 1708
2014
Q2
Sell
-188,470
Closed -$793K 2268
2014
Q1
$793K Sell
188,470
-204,448
-52% -$1.01M ﹤0.01% 1880
2013
Q4
$1.81M Buy
392,918
+271,518
+224% +$1.21M ﹤0.01% 1723
2013
Q3
$751K Buy
+121,400
New +$699K ﹤0.01% 1868

Wellington Management Group's IMMU Position: Q4 2020 in Review

Wellington Management Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 70,778 shares — an estimated $6.02M sold.

Wellington Management Group first reported a position in IMMU in Q3 2013 and held it in 9 quarters. The position peaked at $6.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Wellington Management Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Wellington Management Group sold 70,778 Immunomedics Inc shares in Q4 2020, an estimated $6.02M.
  • Wellington Management Group first reported a position in Immunomedics Inc in Q3 2013 and held it in 9 quarters.
  • Wellington Management Group's Immunomedics Inc position peaked at $6.02M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Wellington Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.